Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd > LBL and COVID-19

<< Previous

Bullboard Posts

Next >>

Post by MaterialWorldon Mar 15, 2020 9:26am

143 Views

Post# 30809310

LBL and COVID-19

LBL Anti-inflamitory Stem Cell treatment is just that, a treatment. With many other types of lung deseases, not just ( ARDS ) acute respiratory distress syndrome caused by coronavirus
( COVID-19 ) LBL is onto something very hot.
AmnioBoost Stem Cell anti-inflamatory technology can also be used as a treatment for many other types of inflamed deseases. And it works

We're onto to something very good. MW

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec